nodes	percent_of_prediction	percent_of_DWPC	metapath
Moxifloxacin—TOP2A—Teniposide—lung cancer	0.393	0.574	CbGbCtD
Moxifloxacin—TOP2A—Etoposide—lung cancer	0.173	0.253	CbGbCtD
Moxifloxacin—TOP2A—Doxorubicin—lung cancer	0.118	0.173	CbGbCtD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—RRAD—lung cancer	0.0022	0.104	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—AXL—lung cancer	0.00167	0.0786	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—TP63—lung cancer	0.000926	0.0436	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—HMGB2—lung cancer	0.000868	0.0408	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—SFN—lung cancer	0.00079	0.0372	CbGpPWpGaD
Moxifloxacin—TOP2A—Docetaxel—Paclitaxel—lung cancer	0.000692	0.0971	CbGdCrCtD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RRM1—lung cancer	0.000658	0.0309	CbGpPWpGaD
Moxifloxacin—Gatifloxacin—ALB—lung cancer	0.000592	0.243	CrCbGaD
Moxifloxacin—TOP2A—Irinotecan—Topotecan—lung cancer	0.000592	0.0831	CbGdCrCtD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MSH6—lung cancer	0.000586	0.0276	CbGpPWpGaD
Moxifloxacin—Norfloxacin—CYP2A6—lung cancer	0.000565	0.232	CrCbGaD
Moxifloxacin—TOP2A—Erlotinib—Gefitinib—lung cancer	0.000516	0.0725	CbGdCrCtD
Moxifloxacin—TOP2A—Gastric Cancer Network 1—APC—lung cancer	0.000494	0.0232	CbGpPWpGaD
Moxifloxacin—TOP2A—Topotecan—Irinotecan—lung cancer	0.000492	0.069	CbGdCrCtD
Moxifloxacin—TOP2A—Etoposide—Teniposide—lung cancer	0.000489	0.0686	CbGdCrCtD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—HES1—lung cancer	0.000455	0.0214	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—KMT2A—lung cancer	0.000444	0.0209	CbGpPWpGaD
Moxifloxacin—TOP2A—Vindesine—Vinorelbine—lung cancer	0.00044	0.0617	CbGdCrCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TOP1—lung cancer	0.000423	0.0199	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—TOP1—lung cancer	0.000406	0.0191	CbGpPWpGaD
Moxifloxacin—Norfloxacin—CYP1A1—lung cancer	0.000396	0.163	CrCbGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—NKX2-1—lung cancer	0.000396	0.0186	CbGpPWpGaD
Moxifloxacin—TOP2A—Podofilox—Teniposide—lung cancer	0.000373	0.0523	CbGdCrCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RHEB—lung cancer	0.00037	0.0174	CbGpPWpGaD
Moxifloxacin—Sparfloxacin—ABCB1—lung cancer	0.000369	0.152	CrCbGaD
Moxifloxacin—TOP2A—Vindesine—Vinblastine—lung cancer	0.000352	0.0493	CbGdCrCtD
Moxifloxacin—TOP2A—Methotrexate—Pemetrexed—lung cancer	0.000351	0.0492	CbGdCrCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NODAL—lung cancer	0.000351	0.0165	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RRM1—lung cancer	0.000351	0.0165	CbGpPWpGaD
Moxifloxacin—TOP2A—Paclitaxel—Docetaxel—lung cancer	0.000345	0.0484	CbGdCrCtD
Moxifloxacin—TOP2A—Afatinib—Gefitinib—lung cancer	0.000338	0.0474	CbGdCrCtD
Moxifloxacin—TOP2A—Gefitinib—Erlotinib—lung cancer	0.000331	0.0465	CbGdCrCtD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—PPP2R1B—lung cancer	0.000313	0.0147	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TYMS—lung cancer	0.000279	0.0131	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RARB—lung cancer	0.000273	0.0128	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—lung cancer	0.000273	0.0128	CbGpPWpGaD
Moxifloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—lung cancer	0.000264	0.0124	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—AHR—lung cancer	0.000262	0.0123	CbGpPWpGaD
Moxifloxacin—Levofloxacin—ABCB1—lung cancer	0.000259	0.107	CrCbGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—MYC—lung cancer	0.000258	0.0121	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—EGFR—lung cancer	0.000252	0.0119	CbGpPWpGaD
Moxifloxacin—Ciprofloxacin—ABCB1—lung cancer	0.000251	0.103	CrCbGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—HPGDS—lung cancer	0.000238	0.0112	CbGpPWpGaD
Moxifloxacin—TOP2A—Vincristine—Vinorelbine—lung cancer	0.000237	0.0333	CbGdCrCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—ADCY1—lung cancer	0.000233	0.011	CbGpPWpGaD
Moxifloxacin—TOP2A—Vinorelbine—Vinblastine—lung cancer	0.000222	0.0311	CbGdCrCtD
Moxifloxacin—TOP2A—Teniposide—Etoposide—lung cancer	0.000222	0.0311	CbGdCrCtD
Moxifloxacin—TOP2A—Podofilox—Etoposide—lung cancer	0.000222	0.0311	CbGdCrCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ANXA1—lung cancer	0.000212	0.01	CbGpPWpGaD
Moxifloxacin—TOP2A—Gastric Cancer Network 2—TP53—lung cancer	0.000212	0.00996	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APP—lung cancer	0.000201	0.00948	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—TYMS—lung cancer	0.000197	0.00925	CbGpPWpGaD
Moxifloxacin—TOP2A—Vinblastine—Vinorelbine—lung cancer	0.000191	0.0268	CbGdCrCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUNB—lung cancer	0.000191	0.00897	CbGpPWpGaD
Moxifloxacin—TOP2A—Vincristine—Vinblastine—lung cancer	0.00019	0.0266	CbGdCrCtD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RB1—lung cancer	0.000189	0.00891	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—STK11—lung cancer	0.000173	0.00815	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—lung cancer	0.000162	0.0076	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—RAF1—lung cancer	0.000161	0.00757	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ABCB1—lung cancer	0.000152	0.00714	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—AVP—lung cancer	0.00015	0.00707	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TYMS—lung cancer	0.000149	0.00701	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—TYMS—lung cancer	0.000143	0.00673	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—lung cancer	0.000141	0.00662	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—FOXM1—lung cancer	0.000138	0.00651	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FASLG—lung cancer	0.000137	0.00644	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDKN1A—lung cancer	0.000136	0.0064	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—RB1—lung cancer	0.000133	0.00627	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGFR1—lung cancer	0.000126	0.00593	CbGpPWpGaD
Moxifloxacin—TOP2A—Cytarabine—Gemcitabine—lung cancer	0.000125	0.0175	CbGdCrCtD
Moxifloxacin—TOP2A—Cell Cycle—FOXM1—lung cancer	0.000124	0.00582	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—lung cancer	0.000117	0.00551	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—PPP2R1B—lung cancer	0.000115	0.00539	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—lung cancer	0.000113	0.00531	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—LMNA—lung cancer	0.000109	0.00515	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—lung cancer	0.000109	0.00514	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGF—lung cancer	0.000108	0.00509	CbGpPWpGaD
Moxifloxacin—TOP2A—Epirubicin—Doxorubicin—lung cancer	0.000107	0.015	CbGdCrCtD
Moxifloxacin—TOP2A—Idarubicin—Doxorubicin—lung cancer	0.000107	0.015	CbGdCrCtD
Moxifloxacin—TOP2A—Daunorubicin—Doxorubicin—lung cancer	0.000107	0.015	CbGdCrCtD
Moxifloxacin—TOP2A—Cell Cycle—PPP2R1B—lung cancer	0.000103	0.00482	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—lung cancer	0.000102	0.00479	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CREBBP—lung cancer	0.000101	0.00477	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—lung cancer	9.9e-05	0.00466	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—LMNA—lung cancer	9.78e-05	0.0046	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAP2K1—lung cancer	9.67e-05	0.00455	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—lung cancer	9.58e-05	0.00451	CbGpPWpGaD
Moxifloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—lung cancer	9.27e-05	0.00436	CbGpPWpGaD
Moxifloxacin—TOP2A—Azacitidine—Gemcitabine—lung cancer	8.94e-05	0.0125	CbGdCrCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—lung cancer	8.61e-05	0.00405	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—RAF1—lung cancer	8.58e-05	0.00404	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—lung cancer	8.49e-05	0.00399	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTGS2—lung cancer	8.3e-05	0.00391	CbGpPWpGaD
Moxifloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—lung cancer	7.94e-05	0.00374	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—lung cancer	7.7e-05	0.00363	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—lung cancer	7.5e-05	0.00353	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	7.48e-05	0.00352	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	7.26e-05	0.00341	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	7.24e-05	0.00341	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—TYMS—lung cancer	7.21e-05	0.00339	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—JUN—lung cancer	7.18e-05	0.00338	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—PTEN—lung cancer	6.95e-05	0.00327	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	6.9e-05	0.00325	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	6.71e-05	0.00316	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—EP300—lung cancer	6.63e-05	0.00312	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	6.54e-05	0.00308	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—lung cancer	6.48e-05	0.00305	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—TYMS—lung cancer	6.45e-05	0.00303	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	6.19e-05	0.00291	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	6.02e-05	0.00283	CbGpPWpGaD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	5.88e-05	0.00277	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—BIRC5—lung cancer	5.8e-05	0.00273	CbGpPWpGaD
Moxifloxacin—Anaphylactic shock—Docetaxel—lung cancer	5.62e-05	0.000197	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—TERT—lung cancer	5.62e-05	0.00264	CbGpPWpGaD
Moxifloxacin—Weight increased—Doxorubicin—lung cancer	5.61e-05	0.000197	CcSEcCtD
Moxifloxacin—Pruritus—Gemcitabine—lung cancer	5.6e-05	0.000196	CcSEcCtD
Moxifloxacin—Urethral disorder—Methotrexate—lung cancer	5.59e-05	0.000196	CcSEcCtD
Moxifloxacin—Feeling abnormal—Etoposide—lung cancer	5.57e-05	0.000195	CcSEcCtD
Moxifloxacin—Hyperglycaemia—Doxorubicin—lung cancer	5.56e-05	0.000195	CcSEcCtD
Moxifloxacin—Diarrhoea—Irinotecan—lung cancer	5.56e-05	0.000195	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	5.56e-05	0.00262	CbGpPWpGaD
Moxifloxacin—Pneumonia—Doxorubicin—lung cancer	5.53e-05	0.000194	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Etoposide—lung cancer	5.53e-05	0.000194	CcSEcCtD
Moxifloxacin—Shock—Docetaxel—lung cancer	5.53e-05	0.000194	CcSEcCtD
Moxifloxacin—Nervous system disorder—Docetaxel—lung cancer	5.51e-05	0.000193	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Docetaxel—lung cancer	5.5e-05	0.000193	CcSEcCtD
Moxifloxacin—Infestation NOS—Doxorubicin—lung cancer	5.5e-05	0.000193	CcSEcCtD
Moxifloxacin—Infestation—Doxorubicin—lung cancer	5.5e-05	0.000193	CcSEcCtD
Moxifloxacin—Visual impairment—Methotrexate—lung cancer	5.49e-05	0.000193	CcSEcCtD
Moxifloxacin—Tachycardia—Docetaxel—lung cancer	5.48e-05	0.000192	CcSEcCtD
Moxifloxacin—Feeling abnormal—Paclitaxel—lung cancer	5.46e-05	0.000192	CcSEcCtD
Moxifloxacin—Skin disorder—Docetaxel—lung cancer	5.46e-05	0.000191	CcSEcCtD
Moxifloxacin—Stevens-Johnson syndrome—Doxorubicin—lung cancer	5.45e-05	0.000191	CcSEcCtD
Moxifloxacin—Hypersensitivity—Cisplatin—lung cancer	5.44e-05	0.000191	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Paclitaxel—lung cancer	5.42e-05	0.00019	CcSEcCtD
Moxifloxacin—Diarrhoea—Gemcitabine—lung cancer	5.42e-05	0.00019	CcSEcCtD
Moxifloxacin—Renal failure—Doxorubicin—lung cancer	5.4e-05	0.00019	CcSEcCtD
Moxifloxacin—Erythema multiforme—Methotrexate—lung cancer	5.39e-05	0.000189	CcSEcCtD
Moxifloxacin—Neuropathy peripheral—Doxorubicin—lung cancer	5.39e-05	0.000189	CcSEcCtD
Moxifloxacin—Dizziness—Irinotecan—lung cancer	5.37e-05	0.000189	CcSEcCtD
Moxifloxacin—Urticaria—Etoposide—lung cancer	5.37e-05	0.000188	CcSEcCtD
Moxifloxacin—Stomatitis—Doxorubicin—lung cancer	5.36e-05	0.000188	CcSEcCtD
Moxifloxacin—Jaundice—Doxorubicin—lung cancer	5.36e-05	0.000188	CcSEcCtD
Moxifloxacin—Anorexia—Docetaxel—lung cancer	5.36e-05	0.000188	CcSEcCtD
Moxifloxacin—Body temperature increased—Etoposide—lung cancer	5.34e-05	0.000187	CcSEcCtD
Moxifloxacin—Abdominal pain—Etoposide—lung cancer	5.34e-05	0.000187	CcSEcCtD
Moxifloxacin—Urinary tract infection—Doxorubicin—lung cancer	5.34e-05	0.000187	CcSEcCtD
Moxifloxacin—Conjunctivitis—Doxorubicin—lung cancer	5.34e-05	0.000187	CcSEcCtD
Moxifloxacin—Eye disorder—Methotrexate—lung cancer	5.33e-05	0.000187	CcSEcCtD
Moxifloxacin—Tinnitus—Methotrexate—lung cancer	5.31e-05	0.000186	CcSEcCtD
Moxifloxacin—Asthenia—Cisplatin—lung cancer	5.29e-05	0.000186	CcSEcCtD
Moxifloxacin—Cardiac disorder—Methotrexate—lung cancer	5.29e-05	0.000186	CcSEcCtD
Moxifloxacin—Sweating—Doxorubicin—lung cancer	5.27e-05	0.000185	CcSEcCtD
Moxifloxacin—Urticaria—Paclitaxel—lung cancer	5.27e-05	0.000185	CcSEcCtD
Moxifloxacin—Hypotension—Docetaxel—lung cancer	5.25e-05	0.000184	CcSEcCtD
Moxifloxacin—Haematuria—Doxorubicin—lung cancer	5.24e-05	0.000184	CcSEcCtD
Moxifloxacin—Body temperature increased—Paclitaxel—lung cancer	5.24e-05	0.000184	CcSEcCtD
Moxifloxacin—Abdominal pain—Paclitaxel—lung cancer	5.24e-05	0.000184	CcSEcCtD
Moxifloxacin—Hepatobiliary disease—Doxorubicin—lung cancer	5.2e-05	0.000182	CcSEcCtD
Moxifloxacin—Epistaxis—Doxorubicin—lung cancer	5.19e-05	0.000182	CcSEcCtD
Moxifloxacin—Angiopathy—Methotrexate—lung cancer	5.17e-05	0.000181	CcSEcCtD
Moxifloxacin—Vomiting—Irinotecan—lung cancer	5.17e-05	0.000181	CcSEcCtD
Moxifloxacin—Sinusitis—Doxorubicin—lung cancer	5.16e-05	0.000181	CcSEcCtD
Moxifloxacin—Immune system disorder—Methotrexate—lung cancer	5.15e-05	0.000181	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Methotrexate—lung cancer	5.14e-05	0.00018	CcSEcCtD
Moxifloxacin—Agranulocytosis—Doxorubicin—lung cancer	5.13e-05	0.00018	CcSEcCtD
Moxifloxacin—Rash—Irinotecan—lung cancer	5.12e-05	0.00018	CcSEcCtD
Moxifloxacin—Dermatitis—Irinotecan—lung cancer	5.12e-05	0.00018	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Docetaxel—lung cancer	5.12e-05	0.00018	CcSEcCtD
Moxifloxacin—Chills—Methotrexate—lung cancer	5.11e-05	0.000179	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	5.11e-05	0.0024	CbGpPWpGaD
Moxifloxacin—Headache—Irinotecan—lung cancer	5.09e-05	0.000179	CcSEcCtD
Moxifloxacin—Insomnia—Docetaxel—lung cancer	5.08e-05	0.000178	CcSEcCtD
Moxifloxacin—Diarrhoea—Cisplatin—lung cancer	5.05e-05	0.000177	CcSEcCtD
Moxifloxacin—Paraesthesia—Docetaxel—lung cancer	5.04e-05	0.000177	CcSEcCtD
Moxifloxacin—Vomiting—Gemcitabine—lung cancer	5.03e-05	0.000177	CcSEcCtD
Moxifloxacin—Bradycardia—Doxorubicin—lung cancer	5.02e-05	0.000176	CcSEcCtD
Moxifloxacin—Dyspnoea—Docetaxel—lung cancer	5.01e-05	0.000176	CcSEcCtD
Moxifloxacin—Somnolence—Docetaxel—lung cancer	4.99e-05	0.000175	CcSEcCtD
Moxifloxacin—Mental disorder—Methotrexate—lung cancer	4.99e-05	0.000175	CcSEcCtD
Moxifloxacin—Rash—Gemcitabine—lung cancer	4.99e-05	0.000175	CcSEcCtD
Moxifloxacin—Dermatitis—Gemcitabine—lung cancer	4.99e-05	0.000175	CcSEcCtD
Moxifloxacin—Hypersensitivity—Etoposide—lung cancer	4.98e-05	0.000175	CcSEcCtD
Moxifloxacin—Malnutrition—Methotrexate—lung cancer	4.96e-05	0.000174	CcSEcCtD
Moxifloxacin—Erythema—Methotrexate—lung cancer	4.96e-05	0.000174	CcSEcCtD
Moxifloxacin—Haemoglobin—Doxorubicin—lung cancer	4.96e-05	0.000174	CcSEcCtD
Moxifloxacin—Headache—Gemcitabine—lung cancer	4.96e-05	0.000174	CcSEcCtD
Moxifloxacin—Rhinitis—Doxorubicin—lung cancer	4.95e-05	0.000174	CcSEcCtD
Moxifloxacin—Dyspepsia—Docetaxel—lung cancer	4.95e-05	0.000173	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	4.94e-05	0.00232	CbGpPWpGaD
Moxifloxacin—Haemorrhage—Doxorubicin—lung cancer	4.94e-05	0.000173	CcSEcCtD
Moxifloxacin—Hepatitis—Doxorubicin—lung cancer	4.94e-05	0.000173	CcSEcCtD
Moxifloxacin—Hypoaesthesia—Doxorubicin—lung cancer	4.91e-05	0.000172	CcSEcCtD
Moxifloxacin—Pharyngitis—Doxorubicin—lung cancer	4.9e-05	0.000172	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—RB1—lung cancer	4.89e-05	0.0023	CbGpPWpGaD
Moxifloxacin—Decreased appetite—Docetaxel—lung cancer	4.88e-05	0.000171	CcSEcCtD
Moxifloxacin—Hypersensitivity—Paclitaxel—lung cancer	4.88e-05	0.000171	CcSEcCtD
Moxifloxacin—Urinary tract disorder—Doxorubicin—lung cancer	4.87e-05	0.000171	CcSEcCtD
Moxifloxacin—Oedema peripheral—Doxorubicin—lung cancer	4.86e-05	0.000171	CcSEcCtD
Moxifloxacin—Dysgeusia—Methotrexate—lung cancer	4.86e-05	0.00017	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Docetaxel—lung cancer	4.85e-05	0.00017	CcSEcCtD
Moxifloxacin—Asthenia—Etoposide—lung cancer	4.85e-05	0.00017	CcSEcCtD
Moxifloxacin—Connective tissue disorder—Doxorubicin—lung cancer	4.85e-05	0.00017	CcSEcCtD
Moxifloxacin—Fatigue—Docetaxel—lung cancer	4.84e-05	0.00017	CcSEcCtD
Moxifloxacin—Urethral disorder—Doxorubicin—lung cancer	4.84e-05	0.00017	CcSEcCtD
Moxifloxacin—Nausea—Irinotecan—lung cancer	4.83e-05	0.000169	CcSEcCtD
Moxifloxacin—Constipation—Docetaxel—lung cancer	4.8e-05	0.000169	CcSEcCtD
Moxifloxacin—Pain—Docetaxel—lung cancer	4.8e-05	0.000169	CcSEcCtD
Moxifloxacin—Back pain—Methotrexate—lung cancer	4.8e-05	0.000168	CcSEcCtD
Moxifloxacin—Pruritus—Etoposide—lung cancer	4.78e-05	0.000168	CcSEcCtD
Moxifloxacin—Visual impairment—Doxorubicin—lung cancer	4.76e-05	0.000167	CcSEcCtD
Moxifloxacin—Asthenia—Paclitaxel—lung cancer	4.76e-05	0.000167	CcSEcCtD
Moxifloxacin—TOP2A—Circadian rythm related genes—TP53—lung cancer	4.74e-05	0.00223	CbGpPWpGaD
Moxifloxacin—Nausea—Gemcitabine—lung cancer	4.7e-05	0.000165	CcSEcCtD
Moxifloxacin—Vomiting—Cisplatin—lung cancer	4.69e-05	0.000165	CcSEcCtD
Moxifloxacin—Pruritus—Paclitaxel—lung cancer	4.69e-05	0.000165	CcSEcCtD
Moxifloxacin—Vision blurred—Methotrexate—lung cancer	4.68e-05	0.000164	CcSEcCtD
Moxifloxacin—Erythema multiforme—Doxorubicin—lung cancer	4.67e-05	0.000164	CcSEcCtD
Moxifloxacin—Rash—Cisplatin—lung cancer	4.65e-05	0.000163	CcSEcCtD
Moxifloxacin—Dermatitis—Cisplatin—lung cancer	4.65e-05	0.000163	CcSEcCtD
Moxifloxacin—Feeling abnormal—Docetaxel—lung cancer	4.63e-05	0.000162	CcSEcCtD
Moxifloxacin—Diarrhoea—Etoposide—lung cancer	4.63e-05	0.000162	CcSEcCtD
Moxifloxacin—Eye disorder—Doxorubicin—lung cancer	4.61e-05	0.000162	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Methotrexate—lung cancer	4.6e-05	0.000161	CcSEcCtD
Moxifloxacin—Tinnitus—Doxorubicin—lung cancer	4.6e-05	0.000161	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Docetaxel—lung cancer	4.59e-05	0.000161	CcSEcCtD
Moxifloxacin—Anaemia—Methotrexate—lung cancer	4.59e-05	0.000161	CcSEcCtD
Moxifloxacin—Cardiac disorder—Doxorubicin—lung cancer	4.58e-05	0.000161	CcSEcCtD
Moxifloxacin—Diarrhoea—Paclitaxel—lung cancer	4.54e-05	0.000159	CcSEcCtD
Moxifloxacin—Angiopathy—Doxorubicin—lung cancer	4.48e-05	0.000157	CcSEcCtD
Moxifloxacin—Malaise—Methotrexate—lung cancer	4.47e-05	0.000157	CcSEcCtD
Moxifloxacin—Dizziness—Etoposide—lung cancer	4.47e-05	0.000157	CcSEcCtD
Moxifloxacin—Immune system disorder—Doxorubicin—lung cancer	4.46e-05	0.000156	CcSEcCtD
Moxifloxacin—Vertigo—Methotrexate—lung cancer	4.46e-05	0.000156	CcSEcCtD
Moxifloxacin—Mediastinal disorder—Doxorubicin—lung cancer	4.45e-05	0.000156	CcSEcCtD
Moxifloxacin—Body temperature increased—Docetaxel—lung cancer	4.44e-05	0.000156	CcSEcCtD
Moxifloxacin—Abdominal pain—Docetaxel—lung cancer	4.44e-05	0.000156	CcSEcCtD
Moxifloxacin—Leukopenia—Methotrexate—lung cancer	4.44e-05	0.000156	CcSEcCtD
Moxifloxacin—Chills—Doxorubicin—lung cancer	4.43e-05	0.000155	CcSEcCtD
Moxifloxacin—Arrhythmia—Doxorubicin—lung cancer	4.41e-05	0.000155	CcSEcCtD
Moxifloxacin—Dizziness—Paclitaxel—lung cancer	4.38e-05	0.000154	CcSEcCtD
Moxifloxacin—Nausea—Cisplatin—lung cancer	4.38e-05	0.000154	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—RB1—lung cancer	4.37e-05	0.00206	CbGpPWpGaD
Moxifloxacin—TOP2A—Circadian rythm related genes—IL6—lung cancer	4.34e-05	0.00204	CbGpPWpGaD
Moxifloxacin—Cough—Methotrexate—lung cancer	4.33e-05	0.000152	CcSEcCtD
Moxifloxacin—Mental disorder—Doxorubicin—lung cancer	4.32e-05	0.000152	CcSEcCtD
Moxifloxacin—Convulsion—Methotrexate—lung cancer	4.3e-05	0.000151	CcSEcCtD
Moxifloxacin—Vomiting—Etoposide—lung cancer	4.3e-05	0.000151	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—lung cancer	4.3e-05	0.00202	CbGpPWpGaD
Moxifloxacin—Erythema—Doxorubicin—lung cancer	4.3e-05	0.000151	CcSEcCtD
Moxifloxacin—Malnutrition—Doxorubicin—lung cancer	4.3e-05	0.000151	CcSEcCtD
Moxifloxacin—Rash—Etoposide—lung cancer	4.26e-05	0.00015	CcSEcCtD
Moxifloxacin—Dermatitis—Etoposide—lung cancer	4.26e-05	0.000149	CcSEcCtD
Moxifloxacin—Headache—Etoposide—lung cancer	4.24e-05	0.000149	CcSEcCtD
Moxifloxacin—Flatulence—Doxorubicin—lung cancer	4.23e-05	0.000149	CcSEcCtD
Moxifloxacin—Myalgia—Methotrexate—lung cancer	4.22e-05	0.000148	CcSEcCtD
Moxifloxacin—Chest pain—Methotrexate—lung cancer	4.22e-05	0.000148	CcSEcCtD
Moxifloxacin—Arthralgia—Methotrexate—lung cancer	4.22e-05	0.000148	CcSEcCtD
Moxifloxacin—Tension—Doxorubicin—lung cancer	4.22e-05	0.000148	CcSEcCtD
Moxifloxacin—Vomiting—Paclitaxel—lung cancer	4.21e-05	0.000148	CcSEcCtD
Moxifloxacin—Dysgeusia—Doxorubicin—lung cancer	4.21e-05	0.000148	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	4.19e-05	0.000147	CcSEcCtD
Moxifloxacin—Rash—Paclitaxel—lung cancer	4.18e-05	0.000147	CcSEcCtD
Moxifloxacin—Dermatitis—Paclitaxel—lung cancer	4.18e-05	0.000146	CcSEcCtD
Moxifloxacin—Discomfort—Methotrexate—lung cancer	4.17e-05	0.000146	CcSEcCtD
Moxifloxacin—Nervousness—Doxorubicin—lung cancer	4.17e-05	0.000146	CcSEcCtD
Moxifloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	4.17e-05	0.00196	CbGpPWpGaD
Moxifloxacin—Back pain—Doxorubicin—lung cancer	4.16e-05	0.000146	CcSEcCtD
Moxifloxacin—Headache—Paclitaxel—lung cancer	4.15e-05	0.000146	CcSEcCtD
Moxifloxacin—Hypersensitivity—Docetaxel—lung cancer	4.14e-05	0.000145	CcSEcCtD
Moxifloxacin—Muscle spasms—Doxorubicin—lung cancer	4.13e-05	0.000145	CcSEcCtD
Moxifloxacin—Confusional state—Methotrexate—lung cancer	4.08e-05	0.000143	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Methotrexate—lung cancer	4.05e-05	0.000142	CcSEcCtD
Moxifloxacin—Vision blurred—Doxorubicin—lung cancer	4.05e-05	0.000142	CcSEcCtD
Moxifloxacin—Asthenia—Docetaxel—lung cancer	4.03e-05	0.000141	CcSEcCtD
Moxifloxacin—Nausea—Etoposide—lung cancer	4.02e-05	0.000141	CcSEcCtD
Moxifloxacin—Ill-defined disorder—Doxorubicin—lung cancer	3.99e-05	0.00014	CcSEcCtD
Moxifloxacin—Pruritus—Docetaxel—lung cancer	3.97e-05	0.000139	CcSEcCtD
Moxifloxacin—Nervous system disorder—Methotrexate—lung cancer	3.97e-05	0.000139	CcSEcCtD
Moxifloxacin—Anaemia—Doxorubicin—lung cancer	3.97e-05	0.000139	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Methotrexate—lung cancer	3.96e-05	0.000139	CcSEcCtD
Moxifloxacin—Agitation—Doxorubicin—lung cancer	3.95e-05	0.000139	CcSEcCtD
Moxifloxacin—Nausea—Paclitaxel—lung cancer	3.94e-05	0.000138	CcSEcCtD
Moxifloxacin—Skin disorder—Methotrexate—lung cancer	3.93e-05	0.000138	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Methotrexate—lung cancer	3.91e-05	0.000137	CcSEcCtD
Moxifloxacin—Malaise—Doxorubicin—lung cancer	3.87e-05	0.000136	CcSEcCtD
Moxifloxacin—Vertigo—Doxorubicin—lung cancer	3.86e-05	0.000135	CcSEcCtD
Moxifloxacin—Anorexia—Methotrexate—lung cancer	3.86e-05	0.000135	CcSEcCtD
Moxifloxacin—Syncope—Doxorubicin—lung cancer	3.85e-05	0.000135	CcSEcCtD
Moxifloxacin—Leukopenia—Doxorubicin—lung cancer	3.85e-05	0.000135	CcSEcCtD
Moxifloxacin—Diarrhoea—Docetaxel—lung cancer	3.84e-05	0.000135	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—CDKN2A—lung cancer	3.84e-05	0.00181	CbGpPWpGaD
Moxifloxacin—Palpitations—Doxorubicin—lung cancer	3.8e-05	0.000133	CcSEcCtD
Moxifloxacin—Hypotension—Methotrexate—lung cancer	3.78e-05	0.000133	CcSEcCtD
Moxifloxacin—Loss of consciousness—Doxorubicin—lung cancer	3.78e-05	0.000132	CcSEcCtD
Moxifloxacin—Cough—Doxorubicin—lung cancer	3.75e-05	0.000132	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—MDM2—lung cancer	3.73e-05	0.00175	CbGpPWpGaD
Moxifloxacin—Convulsion—Doxorubicin—lung cancer	3.72e-05	0.000131	CcSEcCtD
Moxifloxacin—Dizziness—Docetaxel—lung cancer	3.72e-05	0.00013	CcSEcCtD
Moxifloxacin—Hypertension—Doxorubicin—lung cancer	3.71e-05	0.00013	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Methotrexate—lung cancer	3.69e-05	0.000129	CcSEcCtD
Moxifloxacin—Insomnia—Methotrexate—lung cancer	3.66e-05	0.000128	CcSEcCtD
Moxifloxacin—Chest pain—Doxorubicin—lung cancer	3.66e-05	0.000128	CcSEcCtD
Moxifloxacin—Arthralgia—Doxorubicin—lung cancer	3.66e-05	0.000128	CcSEcCtD
Moxifloxacin—Myalgia—Doxorubicin—lung cancer	3.66e-05	0.000128	CcSEcCtD
Moxifloxacin—Anxiety—Doxorubicin—lung cancer	3.64e-05	0.000128	CcSEcCtD
Moxifloxacin—Paraesthesia—Methotrexate—lung cancer	3.64e-05	0.000128	CcSEcCtD
Moxifloxacin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	3.63e-05	0.000127	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—lung cancer	3.63e-05	0.00171	CbGpPWpGaD
Moxifloxacin—Discomfort—Doxorubicin—lung cancer	3.61e-05	0.000127	CcSEcCtD
Moxifloxacin—Dyspnoea—Methotrexate—lung cancer	3.61e-05	0.000127	CcSEcCtD
Moxifloxacin—Somnolence—Methotrexate—lung cancer	3.6e-05	0.000126	CcSEcCtD
Moxifloxacin—Dry mouth—Doxorubicin—lung cancer	3.58e-05	0.000125	CcSEcCtD
Moxifloxacin—Vomiting—Docetaxel—lung cancer	3.57e-05	0.000125	CcSEcCtD
Moxifloxacin—Dyspepsia—Methotrexate—lung cancer	3.56e-05	0.000125	CcSEcCtD
Moxifloxacin—Rash—Docetaxel—lung cancer	3.54e-05	0.000124	CcSEcCtD
Moxifloxacin—Dermatitis—Docetaxel—lung cancer	3.54e-05	0.000124	CcSEcCtD
Moxifloxacin—Confusional state—Doxorubicin—lung cancer	3.54e-05	0.000124	CcSEcCtD
Moxifloxacin—Decreased appetite—Methotrexate—lung cancer	3.52e-05	0.000123	CcSEcCtD
Moxifloxacin—Headache—Docetaxel—lung cancer	3.52e-05	0.000123	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—lung cancer	3.51e-05	0.00165	CbGpPWpGaD
Moxifloxacin—Oedema—Doxorubicin—lung cancer	3.51e-05	0.000123	CcSEcCtD
Moxifloxacin—Anaphylactic shock—Doxorubicin—lung cancer	3.51e-05	0.000123	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Methotrexate—lung cancer	3.5e-05	0.000123	CcSEcCtD
Moxifloxacin—Fatigue—Methotrexate—lung cancer	3.49e-05	0.000122	CcSEcCtD
Moxifloxacin—Pain—Methotrexate—lung cancer	3.46e-05	0.000121	CcSEcCtD
Moxifloxacin—Shock—Doxorubicin—lung cancer	3.45e-05	0.000121	CcSEcCtD
Moxifloxacin—Nervous system disorder—Doxorubicin—lung cancer	3.44e-05	0.000121	CcSEcCtD
Moxifloxacin—Thrombocytopenia—Doxorubicin—lung cancer	3.43e-05	0.00012	CcSEcCtD
Moxifloxacin—Tachycardia—Doxorubicin—lung cancer	3.42e-05	0.00012	CcSEcCtD
Moxifloxacin—Skin disorder—Doxorubicin—lung cancer	3.41e-05	0.000119	CcSEcCtD
Moxifloxacin—Hyperhidrosis—Doxorubicin—lung cancer	3.39e-05	0.000119	CcSEcCtD
Moxifloxacin—Anorexia—Doxorubicin—lung cancer	3.34e-05	0.000117	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—EP300—lung cancer	3.34e-05	0.00157	CbGpPWpGaD
Moxifloxacin—Nausea—Docetaxel—lung cancer	3.34e-05	0.000117	CcSEcCtD
Moxifloxacin—Feeling abnormal—Methotrexate—lung cancer	3.34e-05	0.000117	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Methotrexate—lung cancer	3.31e-05	0.000116	CcSEcCtD
Moxifloxacin—Hypotension—Doxorubicin—lung cancer	3.28e-05	0.000115	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—CCND1—lung cancer	3.25e-05	0.00153	CbGpPWpGaD
Moxifloxacin—Urticaria—Methotrexate—lung cancer	3.22e-05	0.000113	CcSEcCtD
Moxifloxacin—Abdominal pain—Methotrexate—lung cancer	3.2e-05	0.000112	CcSEcCtD
Moxifloxacin—Body temperature increased—Methotrexate—lung cancer	3.2e-05	0.000112	CcSEcCtD
Moxifloxacin—Musculoskeletal discomfort—Doxorubicin—lung cancer	3.19e-05	0.000112	CcSEcCtD
Moxifloxacin—Insomnia—Doxorubicin—lung cancer	3.17e-05	0.000111	CcSEcCtD
Moxifloxacin—Paraesthesia—Doxorubicin—lung cancer	3.15e-05	0.00011	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—CDKN1A—lung cancer	3.14e-05	0.00148	CbGpPWpGaD
Moxifloxacin—Dyspnoea—Doxorubicin—lung cancer	3.13e-05	0.00011	CcSEcCtD
Moxifloxacin—Somnolence—Doxorubicin—lung cancer	3.12e-05	0.000109	CcSEcCtD
Moxifloxacin—Dyspepsia—Doxorubicin—lung cancer	3.09e-05	0.000108	CcSEcCtD
Moxifloxacin—Decreased appetite—Doxorubicin—lung cancer	3.05e-05	0.000107	CcSEcCtD
Moxifloxacin—Gastrointestinal disorder—Doxorubicin—lung cancer	3.03e-05	0.000106	CcSEcCtD
Moxifloxacin—Fatigue—Doxorubicin—lung cancer	3.02e-05	0.000106	CcSEcCtD
Moxifloxacin—Pain—Doxorubicin—lung cancer	3e-05	0.000105	CcSEcCtD
Moxifloxacin—Constipation—Doxorubicin—lung cancer	3e-05	0.000105	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—lung cancer	2.99e-05	0.00141	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—EP300—lung cancer	2.99e-05	0.00141	CbGpPWpGaD
Moxifloxacin—Hypersensitivity—Methotrexate—lung cancer	2.98e-05	0.000105	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle, Mitotic—MYC—lung cancer	2.91e-05	0.00137	CbGpPWpGaD
Moxifloxacin—Asthenia—Methotrexate—lung cancer	2.91e-05	0.000102	CcSEcCtD
Moxifloxacin—Feeling abnormal—Doxorubicin—lung cancer	2.89e-05	0.000101	CcSEcCtD
Moxifloxacin—Gastrointestinal pain—Doxorubicin—lung cancer	2.87e-05	0.000101	CcSEcCtD
Moxifloxacin—Pruritus—Methotrexate—lung cancer	2.86e-05	0.000101	CcSEcCtD
Moxifloxacin—Urticaria—Doxorubicin—lung cancer	2.79e-05	9.77e-05	CcSEcCtD
Moxifloxacin—Abdominal pain—Doxorubicin—lung cancer	2.77e-05	9.72e-05	CcSEcCtD
Moxifloxacin—Body temperature increased—Doxorubicin—lung cancer	2.77e-05	9.72e-05	CcSEcCtD
Moxifloxacin—Diarrhoea—Methotrexate—lung cancer	2.77e-05	9.72e-05	CcSEcCtD
Moxifloxacin—Dizziness—Methotrexate—lung cancer	2.68e-05	9.39e-05	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—MAPK3—lung cancer	2.68e-05	0.00126	CbGpPWpGaD
Moxifloxacin—TOP2A—Cell Cycle—MYC—lung cancer	2.6e-05	0.00123	CbGpPWpGaD
Moxifloxacin—Hypersensitivity—Doxorubicin—lung cancer	2.58e-05	9.06e-05	CcSEcCtD
Moxifloxacin—Vomiting—Methotrexate—lung cancer	2.57e-05	9.03e-05	CcSEcCtD
Moxifloxacin—Rash—Methotrexate—lung cancer	2.55e-05	8.96e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Methotrexate—lung cancer	2.55e-05	8.95e-05	CcSEcCtD
Moxifloxacin—Headache—Methotrexate—lung cancer	2.54e-05	8.9e-05	CcSEcCtD
Moxifloxacin—Asthenia—Doxorubicin—lung cancer	2.52e-05	8.83e-05	CcSEcCtD
Moxifloxacin—Pruritus—Doxorubicin—lung cancer	2.48e-05	8.7e-05	CcSEcCtD
Moxifloxacin—Nausea—Methotrexate—lung cancer	2.41e-05	8.44e-05	CcSEcCtD
Moxifloxacin—Diarrhoea—Doxorubicin—lung cancer	2.4e-05	8.42e-05	CcSEcCtD
Moxifloxacin—Dizziness—Doxorubicin—lung cancer	2.32e-05	8.13e-05	CcSEcCtD
Moxifloxacin—Vomiting—Doxorubicin—lung cancer	2.23e-05	7.82e-05	CcSEcCtD
Moxifloxacin—Rash—Doxorubicin—lung cancer	2.21e-05	7.76e-05	CcSEcCtD
Moxifloxacin—Dermatitis—Doxorubicin—lung cancer	2.21e-05	7.75e-05	CcSEcCtD
Moxifloxacin—Headache—Doxorubicin—lung cancer	2.2e-05	7.71e-05	CcSEcCtD
Moxifloxacin—TOP2A—Cell Cycle—TP53—lung cancer	2.14e-05	0.00101	CbGpPWpGaD
Moxifloxacin—Nausea—Doxorubicin—lung cancer	2.08e-05	7.31e-05	CcSEcCtD
